Norwegian biotech firm Hofseth Biocare narrows losses amid flurry of activity

The company had been reporting poor results throughout the past year.

Jon Olav Ødegård, Hofseth Biocare CFO — Jon Olav Ødegård, Hofseth Biocare CFOPhoto: Anders Furuset

Demi Korban

Published 1 November 2019, 23:18Updated 1 November 2019, 23:18

Hofseth Biocare Atlantic Sapphire Farmed salmon Fish oil Fishmeal